DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Piretanide

Piretanide

  • 5Mg/6Mg Tablets for Example Valsartan, Telmisartan, Irbesartan, Etc.), in Particular Ramipril 5Mg If You Have Diabetes-Related Kidney Problems, • Aliskiren

    5Mg/6Mg Tablets for Example Valsartan, Telmisartan, Irbesartan, Etc.), in Particular Ramipril 5Mg If You Have Diabetes-Related Kidney Problems, • Aliskiren

  • Drug and Medication Classification Schedule

    Drug and Medication Classification Schedule

  • SUMMARY the Effects of Piretanide and Furosemide on Systemic Arterial

    SUMMARY the Effects of Piretanide and Furosemide on Systemic Arterial

  • BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available

    BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available

  • Tubular Action of Diuretics: Distal Effects on Electrolyte Transport and Acidification

    Tubular Action of Diuretics: Distal Effects on Electrolyte Transport and Acidification

  • Azosemide Is More Potent Than Bumetanide and Various Other Loop

    Azosemide Is More Potent Than Bumetanide and Various Other Loop

  • Customs Tariff - Schedule

    Customs Tariff - Schedule

  • Ep 0812320 B

    Ep 0812320 B

  • The Acute Effect of Piretanide Upon Serum and Urinary Calcium in Normal Subjects

    The Acute Effect of Piretanide Upon Serum and Urinary Calcium in Normal Subjects

  • Sulfa Allergy: Cross-Reactivity Versus Multiple Concurrent Allergies

    Sulfa Allergy: Cross-Reactivity Versus Multiple Concurrent Allergies

  • 2021 Equine Prohibited Substances List

    2021 Equine Prohibited Substances List

  • Kava Hepatotoxicity: Comparative Study of Two Structured Quantitative Methods for Causality Assessment

    Kava Hepatotoxicity: Comparative Study of Two Structured Quantitative Methods for Causality Assessment

  • Drug/Substance Trade Name(S)

    Drug/Substance Trade Name(S)

  • Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide

    Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide

  • WO 2014/076235 Al 22 May 2014 (22.05.2014) P O P C T

    WO 2014/076235 Al 22 May 2014 (22.05.2014) P O P C T

  • PRAC Minutes June 2019

    PRAC Minutes June 2019

  • Uniform Classification Guidelines for Foreign Substances, Version 7.00

    Uniform Classification Guidelines for Foreign Substances, Version 7.00

  • Development of an Animal Model of Nephrocalcinosis Via Selective Dietary Sodium and Chloride Depletion

    Development of an Animal Model of Nephrocalcinosis Via Selective Dietary Sodium and Chloride Depletion

Top View
  • Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
  • (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
  • Protective Effect of Loop Diuretics, Piretanide and Frusemide, Against Sodium Metabisulphite-Induced Bronchoconstriction in Asthma
  • NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
  • IV Brazilian Guidelines on Hypertension
  • ARCI CLASSIFICATION PROGRAM V14.1
  • A Quantitative Structure – Toxicity Relationship of Drugs on Rat Summary
  • Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule
  • KENTUCKY HORSE RACING Chapter: \810\008.020REG
  • United States Patent (19) 11 Patent Number: 5,811,547 Nakamichi Et Al
  • Summary of Product Characteristics
  • (12) Patent Application Publication (10) Pub. No.: US 2002/0004065 A1 Kanios (43) Pub
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0256405 A1 CROWLEY Et Al
  • A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
  • Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Illness Code A: Mental Handicap
  • Pharmacovigilance Working Party (Phvwp) March 2011 Plenary Meeting


© 2024 Docslib.org    Feedback